Menu Search
Equities

Sysmex Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SSMXF:PKL

Sysmex Corp

Actions
  • Price (USD)9.88
  • Today's Change0.00 / 0.00%
  • Shares traded7.10k
  • 1 Year change-46.91%
  • Beta0.8033
Data delayed at least 15 minutes, as of Dec 26 2025 13:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.

  • Revenue in JPY (TTM)498.69bn
  • Net income in JPY46.69bn
  • Incorporated1968
  • Employees10.53k
  • Location
    Sysmex Corp1-5-1, Wakinohama Kaigandori, Chuo-kuKOBE-SHI 651-0073JapanJPN
  • Phone+81 782650500
  • Fax+81 782650524
  • Websitehttps://www.sysmex.co.jp
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		6869:TYO since
announced		Transaction
value
JEOL Ltd-Medical Equipment BusinessAnnounced02 Sep 202502 Sep 2025Announced-20.67%--
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.